Abstract: An example of a computer-implemented method includes receiving a surgical protocol for a surgical procedure, a team member identifier for a team member, and team member data associated with a plurality of steps in the surgical protocol. The method further includes determining a number of times that the team member has performed a particular step at an unassisted qualification level. The method further includes determining whether the number of times meets a threshold level. The method further includes, responsive to determining that the number of times does not meet the threshold level, designating the particular step as having an observation requirement by a team leader, and, responsive to determining that the number of times meets the threshold level, designating the particular step as having no observation requirement by the team leader. The plurality of steps in the surgical protocol is then displayed to the team member.

Abstract: A method is provided for localizing an internal bleeding site whereby a protein or other factor involved in the clotting process is complexed to an imaging agent and injected into a patient believed to be at risk of internal bleeding. A clot in the patient will naturally accumulate a certain concentration of the injected complex, and within a short period of time the concentration becomes sufficient to be detected by an imaging apparatus. The imaging contrast agent may, for example, be an MRI contrast agent, a CT contrast agent, a PET agent, or a fluorescent substance.

Abstract: The present invention relates to medical diagnostic techniques and more particularly to compositions and methods for locating an internal bleeding site in a subject.

Abstract: The present invention relates to medical diagnostic techniques and more particularly to compositions and methods for locating an internal bleeding site in a subject.

Abstract: A method is provided for localizing an internal bleeding site whereby a protein or other factor involved in the clotting process is complexed to an imaging agent and injected into a patient believed to be at risk of internal bleeding. A clot in the patient will naturally accumulate a certain concentration of the injected complex, and within a short period of time the concentration becomes sufficient to be detected by an imaging apparatus. The imaging contrast agent may, for example, be an MRI contrast agent, a CT contrast agent, a PET agent, or a fluorescent substance.